![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Sheue C.T.Y. Nag B.
Publisher: Elsevier
ISSN: 0264-410X
Source: Vaccine, Vol.14, Iss.14, 1996-10, pp. : 1313-1321
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Esser M.T. Marchese R.D. Kierstead L.S. Tussey L.G. Wang F. Chirmule N. Washabaugh M.W.
Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Human T-cells recognise N-terminally Fmoc-modified peptide
By Mannering S.I. Purcell A.W. Honeyman M.C. McCluskey J. Harrison L.C.
Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
In vitro senescence models for human T lymphocytes
By Pawelec G. Adibzadeh M. Rehbein A. Hahnel K. Wagner W. Engel A.
Vaccine, Vol. 18, Iss. 16, 2000-02 ,pp. :